应用11项改良衰弱指数确定间歇性跛行患者血管旁路术的准确预后与血运重建策略
本研究回顾了2011至2020年间144例(153条下肢)因间歇性跛行接受腹股沟下旁路术的患者,按mFI-11评分分为高衰弱组(mFI>0.3)和低衰弱组(mFI≤0.3)。低衰弱组与高衰弱组的5年总生存率分别为92%和55%(P<0.001)。多因素分析显示mFI、年龄和终末期肾病是总生存的独立预测因素。静脉移植物与人工血管移植物的5年通畅率和免于主要不良肢体事件率无显著差异。
要点
- mFI-11可用于预测间歇性跛行旁路术患者的总生存。
- 高衰弱组(mFI>0.3)5年总生存率55%,低衰弱组为92%(P<0.001)。
- mFI、年龄和终末期肾病是总生存的独立预测因素。
核心结论
- mFI-11是预测间歇性跛行血管旁路术后总生存的有用工具。
- 高衰弱患者不应接受开放血运重建。
- 对于运动与药物治疗无反应或特别要求更积极治疗的患者,获得良好的衰弱评估评分有助于判断旁路手术是否可行。
研究设计与样本
- 回顾性研究,纳入2011至2020年间连续144例(153条下肢)因间歇性跛行接受腹股沟下旁路术的患者。
- 按mFI-11评分分为高衰弱组(mFI>0.3)和低衰弱组(mFI≤0.3),比较两组总生存率、移植物通畅率和免于主要不良肢体事件率。
主要发现
- 低衰弱组与高衰弱组的5年总生存率分别为92%和55%(P<0.001)。
- 多因素分析显示mFI、年龄和终末期肾病是总生存的独立预测因素。
- 静脉移植物的5年一期通畅率、二期通畅率和免于主要不良肢体事件率分别为81%、91%和94%。
- 人工血管移植物的5年一期通畅率、二期通畅率和免于主要不良肢体事件率分别为65%、80%和84%,差异无统计学意义。
临床怎么用
- 高衰弱(mFI>0.3)的间歇性跛行患者不应接受开放血运重建。
- 对于运动与药物治疗无反应或特别要求更积极治疗的患者,良好的衰弱评估评分有助于判断旁路手术是否可行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In cases of intermittent claudication (IC) where traditionally noninvasive management yields unsatisfactory results, revascularization strategy in IC patients is generally decided based on anatomical considerations and the availability of a saphenous vein graft. Life expectancy should also be considered. This study aimed to investigate the relationship between the 11-item modified frailty index (mFI-11) and the overall survival (OS) in patients with IC who underwent vascular bypass surgery to facilitate revascularization strategy selection. METHODS: We reviewed the records of 144 consecutive patients (153 lower limbs) who underwent infrainguinal bypass for IC between 2011 and 2020. Patients were divided into 2 groups based on their mFI-11 score: high frailty (H), mFI score >0.3; and low frailty (L), mFI score ≤0.3. The OS was compared among the 2 groups. Rates of graft patency and freedom from major adverse limb event (ffMALE) were also determined and compared. RESULTS: Five-year OS in the L and H groups was 92% and 55% (P < 0.001). Multivariate analysis showed that mFI, age, and end-stage renal disease were independent predictors of OS. Five-year rates of primary and secondary patency and ffMALE for vein grafts were 81%, 91%, and 94%, respectively; those for prosthetic grafts were 65%, 80%, and 84%, respectively; the differences were not significant. CONCLUSIONS: The mFI-11 was a helpful tool in predicting OS for patients with IC who underwent vascular bypass surgery. Those with H should not undergo open revascularization; however, for IC patients who have either not responded to a regimen of exercise and medication, or have specifically requested a more aggressive approach, obtaining a good score in frailty assessment is useful in determining whether or not bypass surgery would be a viable option.
引用
- Matsumoto T, Yamashita S, Yoshiga R, et al. Use of the 11-Item Modified Frailty Index to Determine Accurate Prognosis and Revascularization Strategy in Patients Undergoing Vascular Bypass Surgery for Intermittent Claudication. Ann Vasc Surg. 2022. PMID: 36513159. doi:10.1016/j.avsg.2022.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。